SomnoMed (ASX:SOM) Short Percentage of Float


ASX:SOM SomnoMed Ltd ASX:SOM
50 GF Score
Price A$0.54
GF Value A$0.45
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is SomnoMed Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:SOM vs ABT, SYK, MDT: Short Percentage of Float Comparison

For the Medical Devices subindustry, SomnoMed's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SomnoMed Short Percentage of Float vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SomnoMed's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where SomnoMed's Short Percentage of Float falls into.


ASX:SOM
50GF Score
SomnoMed Ltd ASX:SOM
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SomnoMed (ASX:SOM) Overvalued in 2026?

Based on GuruFocus' analysis, SomnoMed stock appears to be overvalued. The current stock price of A$0.54 is trading 18.9% above its estimated GF Value™ of A$0.45. GuruFocus considers SomnoMed to be Modestly Overvalued.

Key valuation signals for ASX:SOM:

  • Short Percentage of Float:
  • GF Value™: A$0.45 vs. price of A$0.54 (18.9% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the ASX:SOM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SomnoMed Business Description

Other Exchanges SOMNF:USARJV:Germany
Address 20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
50GF Score

Get the complete analysis for ASX:SOM

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.54
Price
A$0.45
GF Value